TY - JOUR T1 - Long-Term Health Consequences of Movement Restrictions for Palestinians, 1987–2011 JF - AJPH RESEARCH Y1 - 2018 A1 - Clea A. McNeely A1 - Brian K. Barber A1 - Rita Giacaman A1 - Robert F. Belli A1 - Mahmoud Daher VL - 108 IS - 1 ER - TY - JOUR T1 - Well-being and pressures of daily life in two West Bank villages—Exploring context and history JF - International Journal of Psychology Y1 - 2018 A1 - Yoke Rabaia A1 - Joop de Jong A1 - Anita Abdullah A1 - Rita Giacaman A1 - Peter van de Ven VL - 83 IS - 4 ER - TY - JOUR T1 - The dilemmas of the European Union’s open access to data policy JF - The Lancet Y1 - 2017 A1 - Blandine Destremau A1 - Rita Giacaman A1 - Mona Harb A1 - Linda Herrera A1 - Maria Mexi A1 - Suzan Mitwalli A1 - Emma C Murphy A1 - Yoke Rabaia A1 - Lynn Welchman A1 - Elena Zambelli VL - 390 ER - TY - JOUR T1 - Health research in a turbulent region: the Reproductive Health Working Group Y1 - 2017 A1 - Jocelyn DeJong A1 - Huda Zurayk A1 - Cynthia Myntti A1 - Belgin Tekçe A1 - Rita Giacaman A1 - Hyam Bashour A1 - Atf Ghérissi A1 - Noha Gaballah VL - 25 UR - http://www.tandfonline.com/doi/full/10.1080/09688080.2017.1379864 IS - 1 ER - TY - JOUR T1 - Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments JF - International Journal of Cardiology Y1 - 2016 A1 - Julia Critchley A1 - Simon Capewell A1 - Martin O'Flaherty A1 - Niveen Abu-Rmeileh A1 - Samer Rastam A1 - Olfa Saidi A1 - Kaan Sözmen A1 - Azza Shoaibi A1 - Abdullatif Husseini A1 - Fouad Fouad A1 - Nadia Ben Mansour A1 - Wafa Aissi A1 - Habiba Ben Romdhane A1 - Belgin Unal A1 - Piotr Bandosz A1 - Kathleen Bennett A1 - Mukesh Dherani A1 - Radwan Al Ali A1 - Wasim Maziak A1 - Hale Arýk A1 - Gul Gerceklioolu A1 - Deniz Utku Altun A1 - Hatice Şimşek A1 - Sinem Doganay A1 - Yücel Demiral A1 - Özgür Aslan A1 - Nigel Unwin A1 - Peter Phillimore IS - 208 ER - TY - JOUR T1 - Mental Suffering in Protracted Political Conflict: Feeling Broken or Destroyed JF - PLOS One Y1 - 2016 A1 - Brian K Barber A1 - Clea McNealy A1 - Eyad El Sarraj A1 - Mahmoud Daher A1 - Rita Giacaman A1 - Cairo Arafat A1 - William Barnes A1 - Mohammed Abu Mallouh VL - 11 IS - 5 ER - TY - JOUR T1 - Whither the “Children of the Stone”? An Entire Life under Occupation JF - Journal of Palestine Studies Y1 - 2016 A1 - Brian K Barber A1 - Clea McNeely A1 - Chenoa Allen A1 - Rita Giacaman A1 - Cairo Arafat A1 - Mahmoud Daher A1 - Eyad El-Sarraj A1 - Mohammed Abu Mallouh A1 - Robert F Belli VL - 45 IS - 178 ER - TY - JOUR T1 - Availability and aff ordability of cardiovascular disease medicines and their eff ect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data JF - The Lancet Y1 - 2015 A1 - Rasha Khatib A1 - Martin McKee A1 - Harry Shannon A1 - Clara Chow A1 - Sumathy Rangarajan A1 - Koon Teo A1 - Li Wei A1 - Prem Mony A1 - Viswanathan Mohan A1 - Rajeev Gupta A1 - Rajesh Kumar A1 - Krishnapillai Vijayakumar A1 - Scott A Lear A1 - Rafael Diaz A1 - Alvaro Avezum A1 - Patricio Lopez-Jaramillo A1 - Fernando Lanas A1 - Khalid Yusoff A1 - Noorhassim Ismail A1 - Khawar Kazmi A1 - Omar Rahman A1 - Annika Rosengren A1 - Nahed Monsef A1 - Roya Kelishadi A1 - Annamarie Kruger A1 - Thandi Puoane A1 - Andrzej Szuba A1 - Jephat Chifamba A1 - Ahmet Temizhan A1 - Gilles Dagenais A1 - Amiram Gafni A1 - Salim Yusuf AB -
Background: WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible individuals by 2025. We have previously reported that use of these medicines is very low, but now aim to assess how such low use relates to their lack of availability or poor affordability.
Methods: We analysed information about availability and costs of cardiovascular disease medicines (aspirin, β blockers, angiotensin-converting enzyme inhibitors, and statins) in pharmacies gathered from 596 communities in 18 countries participating in the Prospective Urban Rural Epidemiology (PURE) study. Medicines were considered available if present at the pharmacy when surveyed, and affordable if their combined cost was less than 20% of household capacity-to-pay. We compared results from high-income, upper middle-income, lower middle-income, and low-income countries. Data from India were presented separately given its large, generic pharmaceutical industry.
Findings: Communities were recruited between Jan 1, 2003, and Dec 31, 2013. All four cardiovascular disease medicines were available in 61 (95%) of 64 urban and 27 (90%) of 30 rural communities in high-income countries, 53 (80%) of 66 urban and 43 (73%) of 59 rural communities in upper middle-income countries, 69 (62%) of 111 urban and 42 (37%) of 114 rural communities in lower middle-income countries, eight (25%) of 32 urban and one (3%) of 30 rural communities in low-income countries (excluding India), and 34 (89%) of 38 urban and 42 (81%) of 52 rural communities in India. The four cardiovascular disease medicines were potentially unaffordable for 0·14% of households in high-income countries (14 of 9934 households), 25% of upper middle-income countries (6299 of 24 776), 33% of lower middle-income countries (13 253 of 40 023), 60% of low-income countries (excluding India; 1976 of 3312), and 59% households in India (9939 of 16 874). In low-income and middle-income countries, patients with previous cardiovascular disease were less likely to use all four medicines if fewer than four were available (odds ratio [OR] 0·16, 95% CI 0·04–0·57). In communities in which all four medicines were available, patients were less likely to use medicines if the household potentially could not afford them (0·16, 0·04–0·55).
Interpretation: Secondary prevention medicines are unavailable and unaffordable for a large proportion of communities and households in upper middle-income, lower middle-income, and low-income countries, which have very low use of these medicines. Improvements to the availability and affordability of key medicines is likely to enhance their use and help towards achieving WHO's targets of 50% use of key medicines by 2025.
Funding: Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, GlaxoSmithKline, Novartis, King Pharma, and national or local organisations in participating countries.ER - TY - JOUR T1 - A cross sectional study of maternal ‘near-miss’ cases in major public hospitals in Egypt, Lebanon, Palestine and Syria JF - Pregnancy and Childbirth Y1 - 2015 A1 - Hyam Bashour A1 - Ghada Saad-Haddad A1 - Jocelyn DeJong A1 - Mohammed Cherine Ramadan A1 - Sahar Hassan A1 - Miral Breebaart A1 - Laura Wick A1 - Nevine Hassanein A1 - Mayada Kharouf AB -
VL - 15 UR - http://www.biomedcentral.com/content/pdf/s12884-015-0733-7.pdf IS - 296 ER - TY - RPRT T1 - Facilitators working with the Multi-Family Approach: Part C Manual for Facilitators - Arabic Y1 - 2015 A1 - Trudy Mooren A1 - Yoke van der Meulen A1 - Marguerithe de Man A1 - Relinde Reiffers A1 - Ola Abu Salah A1 - Ameenah Jabali A1 - Manal Rawajbeh A1 - Fathiya Abu Mazin A1 - Iman Daraghmeh A1 - Raja’ Alaza'ar A1 - Wisam Khatatbeh A1 - Iman Odeh A1 - Nabeela Ahmed A1 - Nahreez Aoufi A1 - Hala Bani Odeh A1 - Jihan Alshouli A1 - Rudaina Abu Jarad A1 - Maha Huwwari A1 - Fadia Mardawi PB - War Trauma Foundation CY - The Netherlands ER - TY - RPRT T1 - Facilitators working with the Multi-Family Approach: Part C Manual for Facilitators Y1 - 2015 A1 - Trudy Mooren A1 - Yoke van der Meulen A1 - Marguerithe de Man A1 - Relinde Reiffers A1 - Ola Abu Salah A1 - Ameenah Jabali A1 - Manal Rawajbeh A1 - Fathiya Abu Mazin A1 - Iman Daraghmeh A1 - Raja’ Alaza'ar A1 - Wisam Khatatbeh A1 - Iman Odeh A1 - Nabeela Ahmed A1 - Nahreez Aoufi A1 - Hala Bani Odeh A1 - Jihan Alshouli A1 - Rudaina Abu Jarad A1 - Maha Huwwari A1 - Fadia Mardawi PB - War Trauma Foundation CY - The Netherlands ER - TY - JOUR T1 - A glance into the hidden burden of maternal morbidity and patterns of management in a Palestinian governmental referral hospital JF - Women and Birth Y1 - 2015 A1 - Sahar J. Hassan A1 - Laura Wick A1 - Jocelyn DeJong IS - 463 ER - TY - RPRT T1 - Organisations working with the Multi-Family Approach : Part A Arabic Manual for Organisations Y1 - 2015 A1 - Trudy Mooren A1 - Yoke van der Meulen A1 - Marguerithe de Man A1 - Relinde Reiffers A1 - Ola Abu Salah A1 - Ameenah Jabali A1 - Manal Rawajbeh A1 - Fathiya Abu Mazin A1 - Iman Daraghmeh A1 - Raja’ Alaza'ar A1 - Wisam Khatatbeh A1 - Iman Odeh A1 - Nabeela Ahmed A1 - Nahreez Aoufi A1 - Hala Bani Odeh A1 - Jihan Alshouli A1 - Rudaina Abu Jarad A1 - Maha Huwwari A1 - Fadia Mardawi JF - Organisations working with the Multi-Family Approach ER - TY - RPRT T1 - Organisations working with the Multi-Family Approach : Part A Manual for Organisations - English Y1 - 2015 A1 - Trudy Mooren A1 - Yoke van der Meulen A1 - Marguerithe de Man A1 - Relinde Reiffers A1 - Ola Abu Salah A1 - Ameenah Jabali A1 - Manal Rawajbeh A1 - Fathiya Abu Mazin A1 - Iman Daraghmeh A1 - Raja’ Alaza'ar A1 - Wisam Khatatbeh A1 - Iman Odeh A1 - Nabeela Ahmed A1 - Nahreez Aoufi A1 - Hala Bani Odeh A1 - Jihan Alshouli A1 - Rudaina Abu Jarad A1 - Maha Huwwari A1 - Fadia Mardawi JF - Organisations working with the Multi-Family Approach PB - War Trauma Foundation CY - The Netherlands ER - TY - RPRT T1 - Trainers working with the Multi-Family Approach: Part B Manual for Trainers - Arabic Y1 - 2015 A1 - Trudy Mooren A1 - Yoke van der Meulen A1 - Marguerithe de Man A1 - Relinde Reiffers A1 - Ola Abu Salah A1 - Ameenah Jabali A1 - Manal Rawajbeh A1 - Fathiya Abu Mazin A1 - Iman Daraghmeh A1 - Raja’ Alaza'ar A1 - Wisam Khatatbeh A1 - Iman Odeh A1 - Nabeela Ahmed A1 - Nahreez Aoufi A1 - Hala Bani Odeh A1 - Jihan Alshouli A1 - Rudaina Abu Jarad A1 - Maha Huwwari A1 - Fadia Mardawi PB - War Trauma Foundation CY - The Netherlands ER - TY - RPRT T1 - Trainers working with the Multi-Family Approach: Part B Manual for Trainers - ُEnglish Y1 - 2015 A1 - Trudy Mooren A1 - Yoke van der Meulen A1 - Marguerithe de Man A1 - Relinde Reiffers A1 - Ola Abu Salah A1 - Ameenah Jabali A1 - Manal Rawajbeh A1 - Fathiya Abu Mazin A1 - Iman Daraghmeh A1 - Raja’ Alaza'ar A1 - Wisam Khatatbeh A1 - Iman Odeh A1 - Nabeela Ahmed A1 - Nahreez Aoufi A1 - Hala Bani Odeh A1 - Jihan Alshouli A1 - Rudaina Abu Jarad A1 - Maha Huwwari A1 - Fadia Mardawi PB - War Trauma Foundation CY - The Netherlands ER - TY - JOUR T1 - Human insecurity, chronic economic constraints and health in the occupied Palestinian territory JF - Global Public Health: An International Journal for Research, Policy and Practice Y1 - 2014 A1 - McNeely, Clea. A1 - Barber, Brian K. A1 - Spellings, Carolyn. A1 - Giacaman, R. A1 - Arafat, Cairo. A1 - Daher, Mahmoud. A1 - El Sarraj and Abu Mallouh, Mm. U1 -
Institute of Community and Public Health | This is our slogan.
Jump to navigation
Attempts to establish a health plan for the occupied Palestinian territory were made before the 1993 Oslo Accords. However, the first official national health plan was published in 1994 and aimed to regulate the health sector and integrate the activities of the four main health-care providers: the Palestinian Ministry of Health, Palestinian non-governmental organisations, the UN Relief and Works Agency, and a cautiously developing private sector. However, a decade and a half later, attempts to create an effective, efficient, and equitable system remain unsuccessful. This failure results from arrangements for health care established by the Israeli military government between 1967 and 1994, the nature of the Palestinian National Authority, which has little authority in practice and has been burdened by inefficiency, cronyism, corruption, and the inappropriate priorities repeatedly set to satisfy the preferences of foreign aid donors. Although similar problems exist elsewhere, in the occupied Palestinian territory they are exacerbated and perpetuated under conditions of military occupation. Developmental approaches integrated with responses to emergencies should be advanced to create a more effective, efficient, and equitable health system, but this process would be difficult under military occupation.VL - 373 SN - 1474-547X (Electronic)
BACKGROUND: Information on prescribing practices in Palestine is lacking, however, still essential for strategic planning. PURPOSE: To characterise prescribing patterns and specific medicine use indicators in selected non-governmental organisations' (NGO) primary healthcare clinics/centres (PHC) in the West Bank (WB) in Palestine. METHODOLOGY: A prospective cross-sectional survey of prescribing practices based on medical records of 6032 patients with acute symptoms frequenting 41 NGO PHCs in the WB, between July and September 2004. A systematic random sample of every 10th patient appearing on the patient registration list was selected. Direct observation of consultation and dispensing practices and times in a sub-group of patients was completed utilising special forms. RESULTS: Respiratory tract infections were the most commonly occurring conditions. On average, 1.9 drugs were prescribed per encounter and antibiotics were the most commonly prescribed medications, followed by Analgesics and NSAIDs accounting for 46 and 20% of the total medications expenditures, respectively. Injections and combined medications use per encounter was 16 and 8%, respectively. Most commonly prescribed medications were of local production. Consultation (6.4 +/- 4.6 minutes) and dispensing times (1.6 +/- 1.5 minutes) were short with inadequate labelling. Provision of reference sources and treatment guidelines implementation were also inadequate. CONCLUSION: The results suggest that prescribing practices could be improved through wider implementation of treatment guidelines, a review of antibiotic prescribing, and increased time spent with patients to promote concordance. Strategies aimed at improving prescribing and dispensing practices should be addressed through new innovative capacity building models based on problem solving and feedback mechanisms.VL - 17 SN - 1099-1557 (Electronic)
This paper proposes a new methodology to assess demand and price-elasticity for health care, based on patients' stated willingness to pay (WTP) values for certain aspects of health care quality improvements. A conceptual analysis of how respondents consider contingent valuation (CV) questions allowed us to specify a probability density function of stated WTP values, and consequently, to model a demand function for quality-improved health care, using a parametric survival approach. The model was empirically estimated using a CV study intended to assess patients' values for improving the quality of primary health care (PHC) services in Palestine. A random sample of 499 individuals was interviewed following medical consultation in four PHC centers. Quality was assessed using a multi-attribute approach; and respondents valued seven specific quality improvements using a decomposed valuation scenario and a payment card elicitation technique. Our results suggest an inelastic demand at low user fees levels, and when the price-increase is accompanied with substantial quality-improvements. Nevertheless, demand becomes more and more elastic if user fees continue to rise. On the other hand, patients' reactions to price-increase turn out to depend on their level of income. Our results can be used to design successful health care financing strategies that include a consideration of patients' preferences and financial capacities.VL - 16 SN - 1057-9230 (Print)
Disposal of dental waste was investigated at 37 randomly selected clinics in Ramallah and AI-Bireh cities: 31 private practices and 6 public/NGO clinics. Dentists were interviewed regarding their disposal of different forms of dental waste. Disinfectants and X-ray processing solution were thrown down the drain. For sharps, 13.5% of dentists used puncture-resistant containers (only in the public/ NGO clinics), 45.9% discarded needles directly in the garbage after being recapped and 40.5% placed the used needles and blades in closed plastic bottles before throwing in the general garbage. Blood-soaked dressings and amalgam waste were also thrown in the garbage. While 10.75% of dentists were vaccinated against hepatitis B, 47% of the staff at private clinics were not.VL - 12 Suppl 2 SN - 1020-3397 (Print)
The behavior of dental health personnel was examined with regard to the handling and proper disposal of wastes generated at common dental clinics, and some of the amounts of waste they produce were estimated. In January 2002, a random sample of 37 dental clinics was chosen in the cities of Ramallah and al-Bireh. The visited clinics were distributed between 31 private practices and six public/NGO dental clinics. The dentists were asked about the methods they follow in disposing and discarding of amalgam wastes. An average dentist is estimated to place two small, seven medium and nine large amalgam restorations releasing 22.6 grams of mercury each week. The majority of amalgam wastes ended up in trash or drain.VL - 14 SN - 0960-3123 (Print)
User fees have been promoted as a potential complementary funding mechanism for health care in developing countries. In this paper, we appraise the use of contingent valuation (CV) as a tool to help develop user fees schemes that could be used to assist in allocating, and partially fund, health care. A random sample of 499 patients seeking care in primary health care centers, in Palestine, were asked to reveal their willingness to pay values for specified improvements in the quality of delivered medical care. Empirical analysis suggests that, in this context, CV can lead to internally consistent results and useful policy implications.VL - 23 SN - 0167-6296 (Print)
This article describes the nature and extent of non-fatal injuries sustained by Palestinians during the first three months of the second intifada in late 2000 by looking at two sets of data. 10,279 cases were obtained from the records of the Red Crescent Organization, which provides first level emergency care via ambulance crews in the West Bank and Gaza Strip. For 6,071 cases in the West Bank, additional information was available from the Ministry of Health, which keeps records of first and second emergency level care provided at hospitals and health points. The Ministry of Health cases were classified by type of weapon, site of injury and level of treatment provided. Fifty-eight per cent of injuries occurred in young men 18-34 years, but 25 per cent occurred in school children, ten per cent in people over 50 years and five per cent in females. Fifty-nine per cent of the injuries were caused by bullets and 76 per cent of these affected the upper part of the body; 13.4 per cent of the injuries were severe, with major implication for disability and the need for long-term care and support.VL - 18 SN - 1362-3699 (Print)